A Comparative Study of Peripheral Nerve Ultrasound Findings in Immune Mediated Peripheral Nerve Disorders; a Hospital-based Study

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Observational
SUMMARY

Neuromuscular ultrasound (NMUS) is emerging as a valuable non-invasive diagnostic tool. In GBS, NMUS can detect proximal nerve enlargement early, before neurophysiological changes. Persistent nerve enlargement can be observed up to 15 years, though its correlation with disability varies. Research is needed to clarify NMUS findings in GBS and CIDP over time. Early detection of nerve root enlargement via NMUS could facilitate earlier diagnosis and intervention, improving patient outcomes and understanding of these conditions\' pathophysiology. This study aims to determine if nerve alterations in acute GBS and CIDP detectable by ultrasound match electrodiagnostic findings and if this method aids early diagnosis. The investigators will perform serial nerve ultrasounds and NCS to investigate nerve morphology, predict outcomes, and differentiate between axonal and demyelinating subtypes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• Diagnosis of patient group:

‣ GBS Patients: Diagnosed according to the criteria of the National Institute of Neurological Disorders and Stroke (NINDS) and the Brighton Collaboration (2011).

⁃ CIDP Patients: Diagnosed according to the criteria of the European Federation of Neurological Societies/Peripheral Nerve Society (EFNS/PNS).

• Age: Participants aged 18 to 75 years.

• Onset:

‣ GBS Patients: Recent onset of GBS within the first 2 weeks of symptom onset.

⁃ CIDP Patients: Either relapsing or progressive course consistent with CIDP diagnosis.

• Gender: Both male and female participants are eligible.

• Participation: Willingness to participate in the study, including undergoing disease-related examinations and assessments.

• Consent: Ability and willingness to provide informed consent

Locations
Other Locations
Egypt
Assiut University Hospitals
RECRUITING
Asyut
Contact Information
Primary
Mohammed Gad Ibrahim, MB, BCh
modyurd222@gmail.com
+201022748859
Time Frame
Start Date: 2024-09-01
Estimated Completion Date: 2028-03-30
Participants
Target number of participants: 90
Treatments
Case
Patients with immune mediated peripheral nerve disorders GB syndrome and CIDP
Control
Healthy control matching group
Sponsors
Leads: Assiut University

This content was sourced from clinicaltrials.gov